News

News FDA alerts health care professionals and patients not to use compounded drugs from Cantrell Drug Company

3/02/2018
  • Board of Registration in Pharmacy
  • Bureau of Health Professions Licensure
  • Bureau of Health Care Safety and Quality

FDA Statement

The U.S. Food and Drug Administration is alerting health care professionals and patients not to use drug products produced by Cantrell Drug Company of Little Rock, Arkansas, including opioid products and other drugs intended for sterile injection, that were produced by the company and distributed nationwide.

See the full release on the FDA website.

Board of Registration in Pharmacy 

We track, provide codes for, and set quality standards for pharmacists, pharmacy interns, and pharmacy technicians.

Bureau of Health Professions Licensure 

BHPL oversees the licensing of health care professionals in the state of Massachusetts.

Bureau of Health Care Safety and Quality 

BHCSQ promotes, preserves, and protects the health of all people in the Commonwealth by ensuring an optimal health care delivery system that provides safe, effective, high-quality care.

Feedback

Did you find what you were looking for on this webpage? * required
We use your feedback to help us improve this site but we are not able to respond directly. Please do not include personal or contact information. If you need a response, please locate the contact information elsewhere on this page or in the footer.
We use your feedback to help us improve this site but we are not able to respond directly. Please do not include personal or contact information. If you need a response, please locate the contact information elsewhere on this page or in the footer.

If you need to report child abuse, any other kind of abuse, or need urgent assistance, please click here.

Feedback